doubleinstocks Newsletter
__ _____ Last Trade: $13.48 , UP $0.34 (2.55%) Bank of America Declares Preferred Dividends Bank of America Corporation (NYSE: BAC) yesterday announced the Board of Directors has authorized dividends on preferred stock.
A quarterly cash dividend of $0.38775 per depositary share on the 6.204 percent Non-Cumulative Preferred Stock, Series D, is payable on December 14, 2010 to shareholders of record as of November 30, 2010.
A quarterly cash dividend of $0.255560 per depositary share on the Floating Rate Non-Cumulative Preferred Stock, Series E, is payable on November 15, 2010 to shareholders of record as of October 29, 2010.
A quarterly cash dividend of $0.5125 per depositary share on the 8.20 percent Non-Cumulative Preferred Stock, Series H, is payable on November 1, 2010 to shareholders of record as of October 15, 2010.
Bank of America is one of the world`s largest financial institutions, serving individual consumers, small- and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. The company provides unmatched convenience in the United States, serving approximately 57 million consumer and small business relationships with 5,900 retail banking offices, more than 18,000 ATMs and award-winning online banking with 29 million active users.
Bank of America is among the world`s leading wealth management companies and is a global leader in corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. Bank of America offers industry-leading support to approximately 4 million small business owners through a suite of innovative, easy-to-use online products and services. The company serves clients through operations in more than 40 countries. Bank of America Corporation stock is a component of the Dow Jones Industrial Average and is listed on the New York Stock Exchange.
www.bankofamerica.com _____ Last Trade: $17.14 , UP $0.24 (1.39%) Pfizer Offers First 500,000 Consumers Free Advil to Launch Medicine Cabinet Cleanout Campaign Pfizer Consumer Healthcare (NYSE: PFE), maker of Advil pain-relief products, announced recently the launch of a consumer campaign encouraging Americans to clean out their medicine cabinets and properly dispose of unwanted, expired and recalled products. A recent poll shows that nearly half of Americans do not always look at the expiration date on over-the-counter medications before taking them.(1) To help consumers replenish their medicine cabinets with a trusted and effective over-the-counter pain reliever, Pfizer is providing a coupon for a free bottle of Advil to the first 500,000 eligible people who register. Consumers can register for a coupon for a free bottle by visiting www.MedicineCabinetSafety.com. Pfizer is also partnering with Suzy Cohen, RPh, author of “The 24-Hour Pharmacist” to offer essential tips on medicine cabinet safety.
“This campaign encourages people to take a few simple steps to help ensure the safety of everyone in their household. We all need to de-clutter and clean out our medicine cabinets,” says Dr. Cohen. Below are five important medicine cabinet safety tips:
[*]Clean out regularly: Make sure you schedule a medicine cabinet cleanout every six months.
[*]Check expiration dates: Check the expiration dates of all of the products in your medicine cabinet. Don`t forget about makeup and sunscreen they can expire, too! [*]Check for recalled products: Check the FDA website by visiting www.fda.gov or call the FDA at 888-463-6332 to learn about recalled products and find out if you have any in your medicine cabinet.
[*]Store properly: Keep products in your medicine cabinet stored in a secure area with controlled room temperature and out of the reach of children.
[*]Dispose properly: When disposing of unwanted, expired or recalled products in your medicine cabinet, take precautions to ensure that you protect children, pets and the environment from potentially negative effects. Do not pour any medicines down a sink, toilet or storm drain. For more information on how to properly dispose of medications, ask your pharmacist or go to www.fda.gov and search for “disposal”.
Advil is the leading over-the-counter ibuprofen pain reliever and is one of the top five selling over-the-counter brands in the United States. Advil provides relief from multiple aches and pains — including headaches, backaches, muscle aches and minor arthritis pains. The Advil line of products also includes Children`s Advil, Advil PM, Advil Cold & Sinus, Advil Allergy Sinus, and Advil Congestion Relief.
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world`s best-known consumer products.
www.pfizer.com _____ Proteonomix, Inc. (OTCBB: PROT.OB) Last Trade: $1.85 , UP $0.23 (14.20%) The Science Behind our Cutting-Edge Skin Care Products How It Works Proteoderm has used its expertise in protein technology to develop a unique, natural matrix of proteins called Matrix NC-138T for use in anti-aging skin products.
Matrix NC-138 Bioactive proteins have been defined as specific proteins that have a positive impact on body functions or conditions and may ultimately influence health.
The activity of these biofunctional proteins contained in the isolated Matrix NC-138T NC-138 is based on their inherent amino acid composition and sequence. MatrixNC-138T acts on the skin to enhance activities through the stimulation of collagen and glandular production leading to a reduction of wrinkles.
Anti-Aging Technology This company may be able to reverse the signs of aging without Botox injections.
Proteoderm is another subsidiary of Proteonomix.
Proteoderms expertise in biotechnology led to the development of cutting edge anti-aging skin care products. The Proteoderm system works to revitalize and rejuvenate your own cells to help drastically reverse the effects of aging! Among the many cosmetic actives available, proteins have garnered substantial interest for several years. The main reason is that one of the properties of proteins is the delivery of a chemical message that up or down regulates particular cell functions. An accepted view of protein activity is that their amino-acid constituents have structures which send specific signals to the specific cells, for example to the fibroblasts to increase collagen production.
Particular proteins are therefore ideal cosmetic ingredients that can be used to counteract the formation of wrinkles and loss of skin elasticity. Proteoderm has used its expertise in proteomics and protein technology to develop a unique natural matrix of proteins called MatrixTM NC-138 for use in anti-aging skin products.
About Proteonomix, Inc.
Proteonomix, Inc., a biotechnology company, engages in the development of stem cell therapies primarily for the treatment of diabetes and cardiac therapy, as well as offers cosmeceutical products.
The stem cell therapy involves the introduction of healthy new stem cells to repair and replace damaged or lost cells. It offers product for the treatment of anti-aging and damaged skin. The company develops cosmetic products using its technologies, Secreted Matrix and Matrix NC-138 that is a stem cell derived proteins technology.
It also involves in the operation of retail Web site, Proteoderm.com to sell its anti-aging line of skin care products; develops therapeutic modalities for the treatment of cardiovascular disease; and engages in the reproductive tissue banking, including sperm, ova, ovarian tissue, and testicular tissue.
In addition, the company develops intellectual properties for patent applications, including a medium and scaffolding for enhancing the growth of stem cells, a growth platform for stem cells, a cord blood banking cryopreservation bag, and a device to eliminate malformed stem cells via filtration.
Further, it is developing pre-clinical-stage therapeutic agents and treatments for cancer, diabetes, heart, lung, and kidney diseases, as well as for stem cell bone marrow and organ transplants. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix was founded in 2005 and is based in Mountainside, New Jersey.
http://www.proteonomix.com/
_____ THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability d ue to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If youre looking for a multi display computer to enhance your trading then youll want to visit www.crowntradingsystems.com — The following information is a reminder of your current mailing list subscription:
You are subscribed to the following list:
doubleinstocks.com
Related posts:
- Stock Watch For Monday, September 27, 2010 From DoubleInStocks – Proteonomix
- CRWE, PROT, PWRM – Expanding Infrastructure, Cell Therapies, and Alzheimer
- AMD, PROT – AMD New Support for AMD Opteron 6000 Series and Research of New
- CVD, ESI, PROT – Most Active Stocks to Watch Update! – DoubleInStocks.com
- OXY, BCA – Friday’s Hot Active Stocks to Watch – DoubleInStocks.com
